A Phase 2 Multi-Center Study of Entinostat (SNDX-275) in Patient With Relapsed or Refractory Hodgkin's Lymphoma

Clinical trial NCT00866333 · TERMINATED

Trial details

NCT number: NCT00866333
Sponsor: Syndax Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin's Lymphoma

Start date: 2009-04-13
Primary completion: 2013-02-08
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.